Paper17699366
Light-chain (AL) amyloidosis: diagnosis and treatment.
Sanchorawala V. Clin J Am Soc Nephrol, 2006. Cited by 159 papers, by iCite.
Cite this record
ConductScience Library. Light-chain (AL) amyloidosis: diagnosis and treatment. Papers, record 17699366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17699366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amyloidosis | Major topic |
| Immunoglobulin Light Chains | Major topic |
| Kidney | Major topic |
| Heart Ventricles | |
| Hodgkin Disease | |
| Humans | |
| Microfibrils | |
| Myocardium | |
| Prognosis |
Source PubMed
Cited by90
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 159 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42653701 | Hepatotoxicity Profile of Bortezomib-Containing Regimens for First-Line Multiple Myeloma Treatment. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42653701 | PubMed |
| 40709584 | Modeling immunoglobulin light chain amyloidosis in Caenorhabditis elegans. | Dis Model Mech | 2025 | https://conductscience.org/library/papers/40709584 | PubMed |
| 40330158 | Light-Chain (AL) Amyloidosis as a Rare Cause of Upper Gastrointestinal Bleeding: A Case Report and Systematic Literature Review. | Case Rep Oncol | 2025 | https://conductscience.org/library/papers/40330158 | PubMed |
| 40045069 | Detection of protein oligomers with nanopores. | Nat Rev Chem | 2025 | https://conductscience.org/library/papers/40045069 | PubMed |
| 38642804 | Broken but not beaten: Challenge of reducing the amyloids pathogenicity by degradation. | J Adv Res | 2025 | https://conductscience.org/library/papers/38642804 | PubMed |
| 38338870 | Re-Engineering Therapeutic Anti-Aβ Monoclonal Antibody to Target Amyloid Light Chain. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38338870 | PubMed |
| 38132175 | Autologous Stem Cell Transplant in Hodgkin's and Non-Hodgkin's Lymphoma, Multiple Myeloma, and AL Amyloidosis. | Cells | 2023 | https://conductscience.org/library/papers/38132175 | PubMed |
| 37421149 | Amyloidoma and Plasmacytoma Presented as a Solitary Lung Nodule in a Patient of Multiple Myeloma With AL-Amyloidosis: A Case Report and Review of Literature. | J Investig Med High Impact Case Rep | 2023 | https://conductscience.org/library/papers/37421149 | PubMed |
| 37342296 | Need for Early Recognition of Amyloidosis in Cases of Unexplained Heart Failure: A Case Report. | Cureus | 2023 | https://conductscience.org/library/papers/37342296 | PubMed |
| 37220448 | A Rare Case of Gastrointestinal Amyloidosis Due to Monoclonal Gammopathy of Undetermined Significance. | Cureus | 2023 | https://conductscience.org/library/papers/37220448 | PubMed |
| 37185541 | Non-Perturbative Identification and Subtyping of Amyloidosis in Human Kidney Tissue with Raman Spectroscopy and Machine Learning. | Biosensors (Basel) | 2023 | https://conductscience.org/library/papers/37185541 | PubMed |
| 36982754 | Machine Learning Approaches in Diagnosis, Prognosis and Treatment Selection of Cardiac Amyloidosis. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36982754 | PubMed |
| 36606280 | Changing paradigm in the treatment of amyloidosis: From disease-modifying drugs to anti-fibril therapy. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/36606280 | PubMed |
| 36574171 | A comprehensive overview of AL amyloidosis disease characteristics accumulated over two decades at a single referral center in Korea. | Int J Hematol | 2023 | https://conductscience.org/library/papers/36574171 | PubMed |
| 36444232 | AL Amyloidosis for Cardiologists: Awareness, Diagnosis, and Future Prospects: JACC: CardioOncology State-of-the-Art Review. | JACC CardioOncol | 2022 | https://conductscience.org/library/papers/36444232 | PubMed |
| 36313726 | Clinical characteristics and prognostic value of renal immune complex deposition in patients with light chain amyloidosis. | Front Oncol | 2022 | https://conductscience.org/library/papers/36313726 | PubMed |
| 36164377 | Isolated prostate amyloidosis; a case report. | Urol Case Rep | 2022 | https://conductscience.org/library/papers/36164377 | PubMed |
| 35371791 | Multiple Myeloma and Renal Failure: Mechanisms, Diagnosis, and Management. | Cureus | 2022 | https://conductscience.org/library/papers/35371791 | PubMed |
| 35281154 | Oral amyloidosis: A case report and diagnostic algorithm. | J Oral Maxillofac Pathol | 2021 | https://conductscience.org/library/papers/35281154 | PubMed |
| 34729532 | How to Screen for Monoclonal Gammopathy in Patients With a Suspected Amyloidosis. | JACC CardioOncol | 2021 | https://conductscience.org/library/papers/34729532 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17699366
GET https://conductscience.org/api/papers/v1/17699366/cited_by?page=2